Huawei’s healthcare president outlined plans to pursue additional partnerships with pharmaceutical companies to advance AI-driven solutions in the sector. Further details on specific collaborations or timelines were not immediately available.
The announcement follows ongoing efforts by Huawei to integrate artificial intelligence into healthcare applications, though specifics on implementation or market impact remain unverified at this time.
